PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Clinical trials for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for scarred lungs: ENV-101 trial targets fibrosis
Disease control OngoingThis study tests an experimental drug called ENV-101 in 213 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. The goal is to see if ENV-101 can improve lung function and slow disease progression compared to a placebo. Partic…
Matched conditions: PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
Breathing in xenon: a new MRI test could catch lung scarring early
Knowledge-focused OngoingThis study explores whether a special MRI scan using xenon gas can detect early signs of lung scarring (fibrosis) and related heart problems in people with progressive interstitial lung disease. About 30 adults already on anti-fibrotic medication will be scanned and followed over…
Matched conditions: PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC